# Overseed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/overseed

- Industry: Biotechnology
- Headquarters: France
- Website: www.overseed.fr
- Total disclosed funding: $7.2M
- Latest round: Series A (Jul 3, 2024)
- Investors on record: 2

## About

Founded in 2021 and based in Orléans, France, Overseed operates as a biotechnology company that engages in providing pharmaceutical-grade cannabinoids for pharmaceutical purposes. The company was founded by its CEO, Hugues Peribère. In July 2024, Overseed raised EUR 6.7 million in Series A funding led by Blast.Club and UI Investissement.

Overseed specializes in the production of therapeutic cannabis for pharmaceutical applications. The products and services offered by the company include dried cannabis flowers, which are unprocessed cannabis flowers for medical use; full-spectrum extracts, which are concentrated cannabis extracts containing a variety of cannabinoids; and co-R&D services, which offer research and development collaboration for companies seeking to produce medical-grade cannabis products.

The company plans to use the funds raised in July 2024 to expand medical cannabis production, launch medications in pharmacies, and expand customers by 2025.

## Funding rounds

- Series A, Jul 3, 2024, $7.2M — UI Investissement, Blast.Club

## Investors

- UI Investissement (https://capitalatlas.ai/funds/ui-investissement) — Series A
- Blast.Club (https://capitalatlas.ai/funds/blast-club) — Series A